当前位置：药药网 / 医药文献 /单克隆抗体应对最终药物的生产,配制,递送和稳定性方面的挑战(本栏目收费,不能显示细节,电话13136136841)
关键字：
类型：
下载页码(大于0,小于196)：
单克隆抗体应对最终药物的生产,配制,递送和稳定性方面的挑战 407条(本栏目收费,不能显示细节,电话13136136841)
Tyr oxidation,56,59
56 59
Parathyroid hormone (PTH),111,112
111 112
Particulates evaluation methods,34
34
PEG. See Polyethylene glycol pH control buffers for,107
107
Pharmaceutical development,1
1
contributors to successful,2
2
Physical degradation,67
67
Chemical degradation aggregation,70,73
70 73
of mAb during long-term storage,73,75
73 75
of mAb during unit processing operations,75,77
75 77
conformational changes,68,70
68 70
Polyacrylamide gel electrophoresis(PAGE),21,22
21 22
Polyethylene glycol (PEG),112,114
112 114
Polyolefin (PO),121,122
121 122
Polysorbate 20 (PS20),54,56,125
54 56 125
Polyvinyl chloride (PVC),121,122
121 122
development for mAb,36
36
active concentration of 4D5 HER2 murine mAb,37
37
ELISA-based receptor inhibition assay,38
38
in€vitro assay,36,37
36 37
ex€vivo cell based,35
35
in€vitro analytical based,36
36
in€vivo animal based,35
35
Prefilled syringe,153,154
153 154
filling of highly concentrated mAbs into,160
160
leachables impact,157
157
problems with tungsten,159
159